Methods and compositions for treatment of Myotubular Myopathy using chimeric polypeptides comprising myotubularih 1 (MTM1) polypeptides

Details for Australian Patent Application No. 2010260145 (hide)

Owner 4s3 Bioscience Inc.

Inventors Armstrong, Dustin D.

Agent Shelston IP

Pub. Number AU-A-2010260145

PCT Pub. Number WO2010/148010

Priority 61/268,732 15.06.09 US

Filing date 15 June 2010

Wipo publication date 23 December 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/148010 Priority application(s): WO2010/148010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260146-Crossbar clamp devices

2010260140-Dual-purpose fluid control valve